Looming patent cliffs and shrivelling pipelines have pharma's big players looking for new business models that will allow them to increase their bottom lines.
Issue 9 Mar 2010
Issue 8 Jul 2009
Issue 7 Apr 2009
Issue 6 Nov 2008
Issue 5 Apr 2008
Issue 4 Nov 2007
Issue 3 Mar 2007
Issue 2 Mar 2006
Issue 1 Feb 2006
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Marie Shields
Editor NGP Europe
Latest News by Aaron Randall
Profile: Aaron Randall has been writing about the pharmaceutical industry for the last 12 months, having contributed to Pharma Times on several occasions. He is interested in the fields of research & development and clinical trials and hopes to develop his interest in other fields of the pharmaceutical industry through his work on NextGeneration Pharmaceutical.